Keywords: genelabs, narrows, net, loss, 7m, usa-based, drugmaker
Genelabs narrows net loss in 2006 to $8.7M
Article | 09 April 2007
USA-based drugmaker Genelabs Technologies says that, for the year ended December 31, 2006, it saw revenues of $11.2 million, compared to $6.8 million in 2005, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
